Forus Raises $150 Million At A $3 Billion Valuation For Its AI Specialty Pharmacy Expediter Network

Forus announced $150 million in Series C financing at a $3 billion valuation, bringing its total funding to more than $300 million. The company operates an artificial intelligence (AI) platform that connects physicians, pharmacies, payers, and biopharmaceutical companies in order to reduce friction that delays or prevents consumers from starting treatment for high-cost or complex conditions. Forus plans to use the new funding to expand into additional specialties and care settings, develop its AI agents, and grow its team.

Bain Capital Ventures led the round and invested in the company since its seed round. Existing institutional investors, including Thrive . . .